Day: March 5, 2024

Unique and memorable campaign intended to educate consumers about Demodex blepharitis and XDEMVY, the first and only FDA approved solution for the disease Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out of every 12 adults Campaign will kick off with a Facebook LIVE event on March 7 at 5pm PTA Media Snippet accompanying this announcement is available by clicking on this link. IRVINE, Calif., March 05, 2024 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announces the launch of “Mite Party,” a dynamic, multi-channel consumer marketing campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA approved...

TEL AVIV, Israel, March 05, 2024 (GLOBE NEWSWIRE) — REE Automotive Ltd. (Nasdaq: REE) (“REE” or the “Company”) has been selected by Airbus UpNext, wholly-owned innovation subsidiary of Airbus SE (stock exchange symbol: EADSY), to provide technological know-how based upon its REEcorner® and full-by-wire control systems. “Our fully-by-wire technology was carefully selected by Airbus UpNext to support their need in a research & technology demonstrator,” said Tali Miller, Chief Business Officer of REE. “This contract is a recognition for our fully-by-wire technology.” To learn more about REE’s patented technology and unique value proposition that positions the company to break new ground in e-mobility, visit www.ree.auto. About REE AutomotiveREE Automotive (Nasdaq: REE) is an automotive technology company that allows companies...

SKEL fjárfestingafélag hf.’s Annual General Meeting will be held on Thursday, 7 March 2024 at 16:00 in the Ballroom at the Reykjavík Edition, Austurbakki 2, 101 Reykjavík. The deadline for declaring candidacy for the Board of Directors has passed. The following are the candidates for the Board of Directors of SKEL:Birna Ósk Einarsdóttir Guðni Rafn Eiríksson Jón Ásgeir Jóhannesson Nanna Björk Ásgrímsdóttir Sigurður Kristinn EgilssonFurther information on each candidate and the Nomination Committee’s proposal can be found in the attached document and on SKEL’s website: https://skel.is/en/shareholders/shareholder-meetings The deadline for declaring candidacy for the Nomination Committee has also passed. The following are candidates for the Nomination Committee:Almar Þór Möller Álfheiður Eva ÓladóttirAccording to the code of...

Growing entertainment company adds historic and impactful festival, as it gains momentum leading into 2024 festival season KANSAS CITY, March 05, 2024 (GLOBE NEWSWIRE) — Digital Ally, Inc. (NASDAQ: DGLY) – Kustom Entertainment, Inc. (“Kustom Entertainment”), a premier live event marketing and concert production company and current subsidiary of Digital Ally Inc. (“Digital Ally”) (Nasdaq: DGLY), is thrilled to announce the recent acquisition of the renowned Country Stampede Music Festival. This strategic move marks a significant milestone for Kustom Entertainment, solidifying its presence and influence in the entertainment industry. Established in 1996, the Country Stampede Music Festival is an annual three-day outdoor music and camping extravaganza that has become a cherished tradition, attracting country music enthusiasts from...

TORONTO, March 05, 2024 (GLOBE NEWSWIRE) — NowVertical Group Inc. (“NowVertical” or the “Company”) (TSX-V: NOW) (OTCQB: NOWVF), a leading data analytics and AI solutions company, is pleased to announce it has renewed its contract with one of the oldest of South Africa’s “big four” banks (the “Customer”) for its NOW Privacy software. With this third consecutive renewal, the Customer has agreed to a 3-year $1.5 million commitment paid in the first half of 2024. This demonstrates a transition from previous one-year contracts to a substantial long-term partnership. Under this multi-year renewal, NOW will continue delivering its solutions, services and cutting-edge technology through its NOW Privacy software solution. Among other use cases, NOW Privacy ensures ongoing compliance with the Protection of Personal Information Act (“POPIA”)...

DALLAS, March 05, 2024 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (“HPC”) applications, today announced the Company has closed a previously secured loan agreement with The Bank of North Dakota and Cornerstone Bank for $16 million in site-level financing for its 10MW Jamestown HPC data center campus. The Company intends to use the loan, which has a 5-year term, to support its operations at the standalone data center, which will house graphics processing units (GPUs) and support various HPC/AI applications. “The execution of this attractive financing is a testament to the strength and support of our banking relationships,” said Applied...

BELTSVILLE, Md., March 05, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the publication of a manuscript titled “The FLRT3-UNC5B Checkpoint Pathway Inhibits T Cell-Based Cancer Immunotherapies” in the journal Science Advances, published by the American Association for the Advancement of Science. The publication details preclinical data evaluating the role of Fibronectin Leucine-Rich Transmembrane protein-3 (FLRT3) in the inhibition of T cell activity and the use of a monoclonal antibody to reverse these effects. Axon guidance molecules (AGMs) that regulate axonal growth in the developing nervous system have been shown to play a role in...

CORAL GABLES, Fla., March 05, 2024 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases, today announced that Richard J. Daly, CEO of Catalyst, along with other members of Catalyst’s management team, will participate at the upcoming Barclays 26th Annual Global Healthcare Conference being held in Miami on March 12-14, 2024. Participation Details: Date:   Tuesday, March 12, 2024Format: Catalyst’s management will host 1×1 meetings and a fireside discussion at 1:35 pm ET. A live webcast of the fireside will be available on the Company’s website, and a replay will be accessible...